RxDoctor Payments Data

Emily Clark, APRN

Nurse Practitioner · Owensboro, KYNPI 1568744829

Payments from drug & device makers

$2,080in general payments, 2019–2025

Across 113 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$415
  • Novo Nordisk$195
  • Astellas Pharma US Inc$165
  • Shield Therapeutics Inc$152
  • Biogen$152
  • Hologic Sales And Service, LLC$121
  • plus $880 from 19 others

What the payments were for

  • Food & beverage$2,06699%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,080 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$16,292
Medicare patients
68
Services billed
311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide12$26,040
OzempicSemaglutide21$23,528
JardianceEmpagliflozin22$18,910
MounjaroTirzepatide13$13,068
NexletolBempedoic Acid12$4,704
SynthroidLevothyroxine Sodium46$2,838
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,254
Estradiol88$1,879
Venlafaxine Hcl ErVenlafaxine Hcl36$1,087
Trazodone Hcl58$922
Levothyroxine Sodium139$891
Rosuvastatin Calcium145$777
Metoprolol Succinate46$775
Potassium Chloride34$491
Pantoprazole Sodium46$421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$38$39,10825 claims
Novo NordiskOzempic$195$23,52821 claims
AbbVieSynthroid$415$2,83846 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →